September 28, 2015
Janssen Biotech Inc. voluntarily agreed to dismiss two of its patent infringement claims against Celltrion Inc. in Massachusetts federal court on Monday, trimming the lawsuit it launched to delay Celltrion's proposed biosimilar version of blockbuster biologic Remicade.
August 26, 2015
Janssen Biotech Inc. and Celltrion Inc. are squaring off in Massachusetts federal court with competing views of a recent Federal Circuit interpretation of the Biologics Price Competition and Innovation Act, debating whether it made advance-notice of biosimilar marketing mandatory in all circumstances.